These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24268350)

  • 1. Real-world costs of chronic lymphocytic leukaemia in the Netherlands.
    Holtzer-Goor KM; Bouwmans-Frijters CA; Schaafsma MR; de Weerdt O; Joosten P; Posthuma EF; Wittebol S; Huijgens PC; Mattijssen EJ; Vreugdenhil G; Visser H; Peters WG; Erjavec Z; Wijermans PW; Daenen SM; van der Hem KG; van Oers MH; Groot CA
    Leuk Res; 2014 Jan; 38(1):84-90. PubMed ID: 24268350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study.
    Blommestein HM; Verelst SG; Huijgens PC; Blijlevens NM; Cornelissen JJ; Uyl-de Groot CA
    Ann Hematol; 2012 Dec; 91(12):1945-52. PubMed ID: 22864761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
    Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.
    Tu HA; Bos JH; Woerdenbag HJ; Visser ST; Wilschut JC; van Assen S; de Jong-van den Berg LT; Postma MJ
    Clin Ther; 2010 Jan; 32(1):133-44. PubMed ID: 20171419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patient-specific cost calculation--a good way to evaluate new therapeutic methods].
    Westin J
    Lakartidningen; 2003 Oct; 100(42):3304-6. PubMed ID: 14619039
    [No Abstract]   [Full Text] [Related]  

  • 6. Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011.
    Kater AP; Wittebol S; Chamuleau ME; van Gelder M; J van Oers MH; Hovon CLL Working Party
    Neth J Med; 2011 Oct; 69(10):422-9. PubMed ID: 22058261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
    Perrier L; Lefranc A; Pérol D; Quittet P; Schmidt-Tanguy A; Siani C; de Peretti C; Favier B; Biron P; Moreau P; Bay JO; Lissandre S; Jardin F; Espinouse D; Sebban C
    Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemia.
    Bouwmans C; Janssen J; Huijgens P; Uyl-de Groot C
    J Med Econ; 2009 Jun; 12(2):164-9. PubMed ID: 19606951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and epidemiological burden of chronic lymphocytic leukaemia.
    Redaelli A; Laskin BL; Stephens JM; Botteman MF; Pashos CL
    Eur J Cancer Care (Engl); 2004 Jul; 13(3):279-87. PubMed ID: 15196232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia.
    Breitscheidel L
    J Med Econ; 2008; 11(4):571-84. PubMed ID: 19450068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single unit lymphoma experience: outcome in a Cape Town academic centre.
    Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
    Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma.
    van Agthoven M; Kramer MH; Sonneveld P; van der Hem KG; Huijgens PC; Wijermans PW; Kluin-Nelemans HC; Schaafsma MR; Biesma DH; Mattijssen V; Uyl-de Groot CA; Hagenbeek A
    Haematologica; 2005 Oct; 90(10):1422-32. PubMed ID: 16219580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.
    Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P
    Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukaemia in the Bloemfontein academic hospitals.
    Nel T; Joubert G; van der Ryst E; Bester I
    Cent Afr J Med; 1998 Aug; 44(8):195-9. PubMed ID: 10101418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience.
    Jantunen E; Itälä M; Siitonen T; Juvonen E; Koivunen E; Koistinen P; Volin L; Remes K; Nousiainen T
    Bone Marrow Transplant; 2006 Jun; 37(12):1093-8. PubMed ID: 16699533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia.
    Dutch/Belgium HOVON CLL working group
    Neth J Med; 2016 Feb; 74(2):68-74. PubMed ID: 26951351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukaemia: only treat when symptomatic.
    Prescrire Int; 2002 Oct; 11(61):156-7. PubMed ID: 12378749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion.
    Español I; Büchler T; Ferrá C; Gallardo D; Reyes P; Sarrá J; Domingo A; Romagosa V; Grañena A
    Bone Marrow Transplant; 2003 Feb; 31(3):215-8. PubMed ID: 12621484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Eichhorst B; Hallek M; Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v162-4. PubMed ID: 20555070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.